Giant Biogene Holding Co., Ltd. (2367.HK)
Makes skincare, medical wound dressings, and functional foods from bioactive materials
31.00+0.07%Consumer Defensive
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago-44.2%
The outlook
Giant Biogene is trading near the lower end of its 52-week range at 31, with analyst consensus strongly bullish and an average price target implying ~32% upside from current levels. The stock shows mixed momentum against its moving averages, though valuation metrics appear modest at a trailing P/E of 14.8.
What’s behind the score
Analyst consensusStrong Buy — 1.4 avg of 16 analysts
Price trendMixed vs its moving averages
52-week range16% of the way from its 52-week low to high
Price targetAvg target +32% vs current price
Analyst price target
~12-month · 16 analysts41.07average target+32.5% vs now
Now 31.00
Low 29.50High 82.20
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$32.91B
52-wk high
65.70
52-wk low
24.20
50-day avg
27.40
200-day avg
32.21
Trailing P/E
14.8